Immune Regulation News Volume 14.43 | Dec 09 2022

    0
    72








    2022-12-09 | IRN 14.43


    Immune Regulation News by STEMCELL Technologies
    Vol. 14.43 – 9 December, 2022
    TOP STORY

    Gut Microbiota Promotes Stem Cell Differentiation through Macrophage and Mesenchymal Niches in Early Postnatal Development

    Mouse genetic and organoid co-culture experiments demonstrated that a CD206+ subset of intestinal macrophages secreted Wnt ligands, which maintained the mesenchymal niche cells important for Paneth cell differentiation.
    [Immunity]

    AbstractGraphical Abstract
    ON1096CS-Wallchart Innate Lymphoid -728 x 90
    PUBLICATIONSRanked by the impact factor of the journal

    Phosphofructokinase P Fine-Tunes T Regulatory Cell Metabolism, Function, and Stability in Systemic Autoimmunity

    In Treg cells, a CRISPR-Cas9–enabled Pfkp deletion recapitulated the metabolism of Camk4−/− Treg cells, and improved their function and stability in vitro and in vivo.
    [Science Advances]

    Full Article

    Krüppel-Like Factor 4 Regulates the Cytolytic Effector Function of Exhausted CD8 T Cells

    KLF4-expressing CD8 T cells in exhaustion contexts showed the features of transitory effector CD8 T cells. Enforced KLF4 expression increased CD8 T cell differentiation into transitory effector subsets and enhanced their antitumor immunity.
    [Science Advances]

    Full ArticlePress Release

    CD1a Promotes Systemic Manifestations of Skin Inflammation

    CD1a is a virtually monomorphic major histocompatibility complex class I-like molecule, highly expressed by skin and mucosal Langerhans cells, and presents lipid antigens to T-cells. Researchers showed an important role for CD1a in linking cutaneous and systemic inflammation in two experimental models.
    [Nature Communications]

    Full Article

    A Conserved Population of MHC II-Restricted, Innate-Like, Commensal-Reactive T Cells in the Gut of Humans and Mice

    The conserved cell population was abundant in the human and murine colon, and endowed with polyfunctional effector properties spanning classic Th1- and Th17-cytokines, cytotoxic molecules, and regulators of epithelial homeostasis.
    [Nature Communications]

    Full Article

    Setd2 Supports GATA3+ST2+ Thymic-Derived Treg Cells and Suppresses Intestinal Inflammation

    Setd2, a histone H3K36 methyltransferase, supported GATA3+ST2+ intestinal thymic-derived Treg (tTreg) cells by facilitating the expression and reciprocal relationship of GATA3 and ST2 in tTreg cells.
    [Nature Communications]

    Full Article

    PD-1 and TIM-3 Differentially Regulate Subsets of Mouse IL-17A–Producing γδ T Cells

    Using single-cell RNA sequencing and flow cytommetry, investigators showed that lung Vγ4+ and Vγ6+ cells from tumor-free and tumor-bearing mice expressed contrasting cell surface molecules as well as distinct co-inhibitory molecules.
    [Journal of Experimental Medicine]

    Full Article

    Extracellular Galectin 4 Drives Immune Evasion and Promotes T-Cell Apoptosis in Pancreatic Cancer

    In orthotopic transplantation experiments, scientists observed increased infiltration of T cells and prolonged survival in immunocompetent mice transplanted with cancer cells with reduced expression of gal 4.
    [Cancer Immunology Research]

    Full Article

    GABA Regulates IL-1β Production in Macrophages

    Mechanistically, GABA enhanced succinate-flavin adenine dinucleotide-lysine specific demethylase1 signaling to regulate histone demethylation of Bcl2l11 and Dusp2.
    [Cell Reports]

    AbstractFull ArticleGraphical Abstract
    Download the cell separation e-book, a practical guide on everything you need to know about cell isolation techniques.
    REVIEWS

    Potential of TCR Sequencing in Graft-Versus-Host Disease

    The authors provide insights into current studies of the T cell receptors repertoire in graft-versus-host disease, and potential future clinical implications of T cell receptor sequencing.
    [Bone Marrow Transplantation]

    Full Article
    INDUSTRY AND POLICY NEWS

    $5 Billion Bispecific Antibody Pharma Collaboration

    Biopharma Akeso Inc. has announced it will enter into a collaboration potentially worth up to $5 billion with Summit Therapeutics Inc., by out-licensing its breakthrough bispecific antibody, ivonescimab for development and commercialisation in the US, Canada, Europe, and Japan.
    [European Pharmaceutical Review]

    Press Release
    FEATURED EVENT

    4th Growth Factors in Regeneration and Regenerative Medicine Conference

    February 9 – 12, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Immunology and Liver Disease

    The Ottawa Hospital Research Institute – Ottawa, Ontario, Canada

    Postdoctoral Scientist – Neuroimmune Organoids

    VIB-UAntwerp – Antwerp, Belgium

    Tenure Track Positions – Precision Oncology and Immuno-Oncology

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Postdoctoral Position – Maternal Immune System

    Case Western Reserve University – Cleveland, Ohio, United States

    Animal Technician – Regenerative Immunology

    Lund University – Lund, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immune Regulation News Twitter